Sarvajna Dwivedi
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems 4
-
- Inhalation and Respiratory Drug Delivery 15
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Respiratory and Cough-Related Research 3
- Spectroscopy top 10%
-
- Asthma and respiratory diseases 6
-
- Advanced Chemical Sensor Technologies 3
- Innovative Microfluidic and Catalytic Techniques Innovation 1
-
- Granular flow and fluidized beds 2
- Co-authors
- A.G. MitchellReinhard VehringDavid Lechuga‐BallesterosMartyn D. TicehurstP. YorkR.C. RoweSaeed SattariFakhreddin Jamali
- Journals
- International Journal of Pharmaceutics (2 papers)Journal of Pharmacy and Pharmacology (2 papers)Respiratory Research (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Sarvajna Dwivedi
23 papers receiving 480 citations
Peers
Comparison fields: 5 of 64
- Pharmaceutical Science 129
- Pulmonary and Respiratory Medicine 265
- Spectroscopy 99
- Physiology 151
- Food Science 68
Countries citing papers authored by Sarvajna Dwivedi
This map shows the geographic impact of Sarvajna Dwivedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarvajna Dwivedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarvajna Dwivedi more than expected).
Fields of papers citing papers by Sarvajna Dwivedi
This network shows the impact of papers produced by Sarvajna Dwivedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarvajna Dwivedi. The network helps show where Sarvajna Dwivedi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarvajna Dwivedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 21 | |
| 2 | 2017 | 37 | |
| 3 | 2017 | 29 | |
| 4 | 2016 | 14 | |
| 5 | 2016 | 6 | |
| 6 | 2016 | 2 | |
| 7 | Dose Proportionality in a Triple Therapy Cosuspension pMDI with Multiple Strengths of an Inhaled Corticosteroid | 2013 | 1 |
| 8 | Hplc analysis of sinapic acid in Lepidium sativum. | 2012 | 5 |
| 9 | 2012 | 2 | |
| 10 | 2012 | 1 | |
| 11 | Highly efficient dual and triple combination therapies with no coformulation effect for treatment of COPD | 2012 | 1 |
| 12 | 2011 | 44 | |
| 13 | 2010 | 0 | |
| 14 | 2010 | 8 | |
| 15 | 2010 | 6 | |
| 16 | 2008 | 2 | |
| 17 | 2002 | 31 | |
| 18 | 1996 | 74 | |
| 19 | 1992 | 65 | |
| 20 | 1989 | 21 |
About Sarvajna Dwivedi
Sarvajna Dwivedi is a scholar working on Pharmaceutical Science, Filtration and Separation, Pulmonary and Respiratory Medicine, Physiology and Biochemistry, having authored 24 papers that have together received 496 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (15 papers), Asthma and respiratory diseases (6 papers), Drug Solubulity and Delivery Systems (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Respiratory and Cough-Related Research (3 papers), Advanced Chemical Sensor Technologies (3 papers), Granular flow and fluidized beds (2 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). The work is most often cited by research in Pharmaceutical Science (129 citations), Pulmonary and Respiratory Medicine (265 citations), Spectroscopy (99 citations), Physiology (151 citations) and Food Science (68 citations). Sarvajna Dwivedi has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include A.G. Mitchell, Reinhard Vehring, David Lechuga‐Ballesteros, Martyn D. Ticehurst, P. York, R.C. Rowe, Saeed Sattari, Fakhreddin Jamali, Gary T. Ferguson and Gary H. Ward. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmacy and Pharmacology, Respiratory Research, Pharmaceutical Research and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.